{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:24:18Z","timestamp":1792110258747,"version":"4.4.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":502,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"NIH","award":["R01 R01EY015130"],"award-info":[{"award-number":["R01 R01EY015130"]}]},{"name":"NIH","award":["R01EY017011"],"award-info":[{"award-number":["R01EY017011"]}]},{"DOI":"10.13039\/100000912","name":"March of Dimes","doi-asserted-by":"crossref","award":["MOD 6-FY08-590"],"award-info":[{"award-number":["MOD 6-FY08-590"]}],"id":[{"id":"10.13039\/100000912","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.ajpath.2011.11.031","type":"journal-article","created":{"date-parts":[[2012,1,9]],"date-time":"2012-01-09T19:19:16Z","timestamp":1326136756000},"page":"1243-1253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["VEGF-Mediated STAT3 Activation Inhibits Retinal Vascularization by Down-Regulating Local Erythropoietin Expression"],"prefix":"10.1016","volume":"180","author":[{"given":"Haibo","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Byfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanchao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George Wesley","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"McCloskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Elizabeth","family":"Hartnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2011.11.031_bib1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10456-007-9066-0","article-title":"Retinopathy of prematurity","volume":"10","author":"Chen","year":"2007","journal-title":"Angiogenesis"},{"key":"10.1016\/j.ajpath.2011.11.031_bib2","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1136\/bjo.2006.098582","article-title":"The Early Treatment for Retinopathy Of Prematurity Study: structural findings at age 2 years","volume":"90","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajpath.2011.11.031_bib3","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0161-6420(93)31665-9","article-title":"Prognostic factors in the natural course of retinopathy of prematurity","volume":"100","author":"Schaffer","year":"1993","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajpath.2011.11.031_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00055735-199706000-00005","article-title":"Clinical implications of vascular growth factors in proliferative retinopathies","volume":"8","author":"Aiello","year":"1997","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ajpath.2011.11.031_bib5","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00417-010-1315-z","article-title":"A review of clinical trials of anti-VEGF agents for diabetic retinopathy","volume":"248","author":"Nicholson","year":"2010","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajpath.2011.11.031_bib6","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1167\/iovs.10-6097","article-title":"Predictors of short-term visual outcome after anti-VEGF therapy of macular edema due to central retinal vein occlusion","volume":"52","author":"Wolf-Schnurrbusch","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajpath.2011.11.031_bib7","first-page":"526","article-title":"Erythropoietin deficiency decreases vascular stability in mice","volume":"118","author":"Chen","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2011.11.031_bib8","doi-asserted-by":"crossref","first-page":"10589","DOI":"10.1073\/pnas.0702031104","article-title":"From the Cover: iGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth","volume":"104","author":"Lofqvist","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2011.11.031_bib9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1542\/peds.109.1.12","article-title":"Long-term ophthalmic outcome of low birth weight children with and without retinopathy of prematurity","volume":"109","author":"O'Connor","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajpath.2011.11.031_bib10","doi-asserted-by":"crossref","first-page":"10595","DOI":"10.1073\/pnas.0702072104","article-title":"IGF binding protein-3 regulates hematopoietic stem cell and endothelial precursor cell function during vascular development","volume":"104","author":"Chang","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2011.11.031_bib11","first-page":"840","article-title":"Inhibition of NAD(P)H oxidase reduces apoptosis and avascular retina in an animal model of retinopathy of prematurity","volume":"13","author":"Saito","year":"2007","journal-title":"Mol Vis"},{"key":"10.1016\/j.ajpath.2011.11.031_bib12","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1023\/A:1022474120512","article-title":"Therapeutic effect of liposomal superoxide dismutase in an animal model of retinopathy of prematurity","volume":"22","author":"Niesman","year":"1997","journal-title":"Neurochem Res"},{"key":"10.1016\/j.ajpath.2011.11.031_bib13","first-page":"345","article-title":"Neutralizing antibody to VEGF reduces intravitreous neovascularization and does not interfere with vascularization of avascular retina in an ROP model","volume":"14","author":"Geisen","year":"2008","journal-title":"Mol Vis"},{"key":"10.1016\/j.ajpath.2011.11.031_bib14","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1203\/00006450-199412000-00007","article-title":"Exposure to alternating hypoxia and hyperoxia causes severe proliferative retinopathy in the newborn rat","volume":"36","author":"Penn","year":"1994","journal-title":"Pediatr Res"},{"key":"10.1016\/j.ajpath.2011.11.031_bib15","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/S0140-6736(95)92475-2","article-title":"Transcutaneous oxygen levels in retinopathy of prematurity","volume":"346","author":"Cunningham","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.ajpath.2011.11.031_bib16","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1167\/iovs.06-0450","article-title":"Triamcinolone reduces neovascularization. capillary density and IGF-1 receptor phosphorylation in a model of oxygen-induced retinopathy","volume":"47","author":"Hartnett","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajpath.2011.11.031_bib17","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1167\/iovs.06-0016","article-title":"The retinal vasculature and function of the neural retina in a rat model of retinopathy of prematurity","volume":"47","author":"Liu","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajpath.2011.11.031_bib18","first-page":"3429","article-title":"Oxygen-induced retinopathy in the rat: relationship of retinal nonperfusion to subsequent neovascularization","volume":"35","author":"Penn","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajpath.2011.11.031_bib19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00004397-199803820-00007","article-title":"Angiogenic factors in diabetic ocular disease: mechanisms of today, therapies for tomorrow","volume":"38","author":"Robinson","year":"1998","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.ajpath.2011.11.031_bib20","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0002-9394(14)75794-0","article-title":"Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy","volume":"118","author":"Adamis","year":"1994","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajpath.2011.11.031_bib21","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1001\/archophthalmol.2010.158","article-title":"Association of retinal vascular endothelial growth factor with avascular retina in a rat model of retinopathy of prematurity","volume":"128","author":"Budd","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajpath.2011.11.031_bib22","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1002\/dvdy.22394","article-title":"Organogenesis and tumorigenesis: insight from the JAK\/STAT pathway in the Drosophila eye","volume":"239","author":"Wang","year":"2010","journal-title":"Dev Dyn"},{"key":"10.1016\/j.ajpath.2011.11.031_bib23","doi-asserted-by":"crossref","first-page":"5552","DOI":"10.1038\/sj.onc.1208719","article-title":"Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways","volume":"24","author":"Xu","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.ajpath.2011.11.031_bib24","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1167\/iovs.08-3256","article-title":"Supplemental oxygen can cause intravitreous neovascularization through JAK\/STAT pathways in a model of retinopathy of prematurity","volume":"50","author":"Byfield","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajpath.2011.11.031_bib25","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/379645a0","article-title":"Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor","volume":"379","author":"Meydan","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2011.11.031_bib26","doi-asserted-by":"crossref","first-page":"F653","DOI":"10.1152\/ajprenal.00163.2003","article-title":"Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli","volume":"286","author":"Banes","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.ajpath.2011.11.031_bib27","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1167\/iovs.05-0673","article-title":"Angiostatic effect of penetrating ocular injury: role of pigment epithelium-derived factor","volume":"47","author":"Penn","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajpath.2011.11.031_bib28","first-page":"1201","article-title":"The effect of oxygen on vasoformative cell division: evidence that \u2018physiological hypoxia\u2019 is the stimulus for normal retinal vasculogenesis","volume":"36","author":"Chan-Ling","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajpath.2011.11.031_bib29","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.1523\/JNEUROSCI.15-07-04738.1995","article-title":"Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia","volume":"15","author":"Stone","year":"1995","journal-title":"J Neurosci"},{"key":"10.1016\/j.ajpath.2011.11.031_bib30","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(98)07130-X","article-title":"Brain structure and neurocognitive and behavioural function in adolescents who were born very preterm","volume":"353","author":"Stewart","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ajpath.2011.11.031_bib31","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/emboj\/cdg117","article-title":"HLF\/HIF-2alpha is a key factor in retinopathy of prematurity in association with erythropoietin","volume":"22","author":"Morita","year":"2003","journal-title":"EMBO J"},{"key":"10.1016\/j.ajpath.2011.11.031_bib32","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jaapos.2007.08.009","article-title":"Human recombinant erythropoietin and the incidence of retinopathy of prematurity: a multiple regression model","volume":"12","author":"Suk","year":"2008","journal-title":"J AAPOS"},{"key":"10.1016\/j.ajpath.2011.11.031_bib33","doi-asserted-by":"crossref","first-page":"19898","DOI":"10.1073\/pnas.0805817105","article-title":"Prolyl hydroxylase inhibition during hyperoxia prevents oxygen-induced retinopathy","volume":"105","author":"Sears","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2011.11.031_bib34","doi-asserted-by":"crossref","first-page":"e681","DOI":"10.1542\/peds.2008-2701","article-title":"Higher cumulative doses of erythropoietin and developmental outcomes in preterm infants","volume":"124","author":"Brown","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajpath.2011.11.031_bib35","first-page":"512","article-title":"VEGF isoforms and their expression after a single episode of hypoxia or repeated fluctuations between hyperoxia and hypoxia: relevance to clinical ROP","volume":"10","author":"McColm","year":"2004","journal-title":"Mol Vis"},{"key":"10.1016\/j.ajpath.2011.11.031_bib36","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1167\/iovs.07-1356","article-title":"Activated NAD(P)H oxidase from supplemental oxygen induces neovascularization independent of VEGF in retinopathy of prematurity model","volume":"49","author":"Saito","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajpath.2011.11.031_bib37","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1542\/peds.2006-1088","article-title":"Genetic susceptibility to retinopathy of prematurity","volume":"118","author":"Bizzarro","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajpath.2011.11.031_bib38","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1157\/13084171","article-title":"Retinopathy of prematurity and oxidative stress ]in Spanish]","volume":"64","author":"Cervantes-Mungu\u00eda","year":"2006","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.ajpath.2011.11.031_bib39","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0002-9440(10)63001-5","article-title":"Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic retinopathy","volume":"167","author":"Al Shabrawey","year":"2005","journal-title":"Am J Path"},{"key":"10.1016\/j.ajpath.2011.11.031_bib40","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/0002-9394(53)91779-6","article-title":"Oxygen studies in retrolental fibroplasia","volume":"36","author":"Patz","year":"1953","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajpath.2011.11.031_bib41","first-page":"137","article-title":"The mode of development of the vascular system of the retina","volume":"68","author":"Michaelson","year":"1948","journal-title":"Trans Ophthal Soc UK"},{"key":"10.1016\/j.ajpath.2011.11.031_bib42","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/bjo.38.7.397","article-title":"Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasia","volume":"38","author":"Ashton","year":"1954","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajpath.2011.11.031_bib43","doi-asserted-by":"crossref","first-page":"10457","DOI":"10.1073\/pnas.92.23.10457","article-title":"Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins","volume":"92","author":"Aiello","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2011.11.031_bib44","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1167\/iovs.08-1780","article-title":"Neutralizing VEGF decreases tortuosity and alters endothelial cell division orientation in arterioles and veins in rat model of ROP: relevance to plus disease","volume":"49","author":"Hartnett","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajpath.2011.11.031_bib45","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1096\/fj.02-1084fje","article-title":"VEGF differentially activates STAT3 in microvascular endothelial cells","volume":"17","author":"Bartoli","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.ajpath.2011.11.031_bib46","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jaapos.2005.09.005","article-title":"Association between higher cumulative doses of recombinant erythropoietin and risk for retinopathy of prematurity","volume":"10","author":"Brown","year":"2006","journal-title":"J AAPOS"},{"key":"10.1016\/j.ajpath.2011.11.031_bib47","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1167\/iovs.08-2521","article-title":"Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy","volume":"50","author":"Chen","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajpath.2011.11.031_bib48","doi-asserted-by":"crossref","first-page":"40026","DOI":"10.1074\/jbc.M301866200","article-title":"Nuclear translocation of phosphorylated STAT3 Is essential for vascular endothelial growth factor-induced human dermal microvascular endothelial cell migration and tube formation","volume":"278","author":"Yahata","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2011.11.031_bib49","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1096\/fj.06-5895fje","article-title":"Differential role of Jak-STAT signaling in retinal degenerations","volume":"20","author":"Samardzija","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.ajpath.2011.11.031_bib50","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1242\/jcs.00963","article-title":"The JAK\/STAT signaling pathway","volume":"117","author":"Rawlings","year":"2004","journal-title":"J Cell Sci"},{"key":"10.1016\/j.ajpath.2011.11.031_bib51","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/IAE.0b013e318177f934","article-title":"Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II","volume":"28","author":"Mintz-Hittner","year":"2008","journal-title":"Retina"},{"key":"10.1016\/j.ajpath.2011.11.031_bib52","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.exer.2009.06.011","article-title":"Reduction in endothelial tip cell filopodia corresponds to reduced intravitreous but not intraretinal vascularization in a model of ROP","volume":"89","author":"Budd","year":"2009","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ajpath.2011.11.031_bib53","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1016\/S0024-3205(99)00526-3","article-title":"Effects of intraocular or systemic administration of neutralizing antibody against vascular endothelial growth factor on the murine experimental model of retinopathy","volume":"65","author":"Sone","year":"1999","journal-title":"Life Sci"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944011010996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944011010996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T14:38:53Z","timestamp":1757601533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944011010996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0002944011010996"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2011.11.031","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"VEGF-Mediated STAT3 Activation Inhibits Retinal Vascularization by Down-Regulating Local Erythropoietin Expression","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2011.11.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}